CELL-DYN 22 TRI-LEVEL CONTROL 93111-01

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,04 report with the FDA on 2007-09-06 for CELL-DYN 22 TRI-LEVEL CONTROL 93111-01 manufactured by Abbott Diagnostics Division/celldyn.

Event Text Entries

[16106499] The customer observed the low and high controls were out of range high for the neutrophil parameter for cell-dyn 22 platelet control lot 0125. The customer reports that samples are acceptable. The customer was sent a new lot of controls. Additionally, the abbott field service representative readjusted and recalibrated the analyzer and the test run was acceptable. It is unk if there was impact to pt management.
Patient Sequence No: 1, Text Type: D, B5


[16119618] Platelet recovery values were out of range high during stability testing for the cell-dyn 22 calibrators, lots 3099, 3098, and 3100 and cell-dyn 22 control lot 0125 for the cd3200 and/or cd ruby optical analyzers. Cell-dyn 22 calibrator lot 3098 did not meet shelf life stability on the cell-dyn 3200 analyzer at its expiry. Cell-dyn 22 calibrator lot 3099 did not meet shelf life stability and the 7 day open vial stability for the platelet parameter on the cell-dyn ruby analyzer. Internal data indicated that cell-dyn 22 calibrator lot 3100 was experiencing the same issues as it approached the october 6, 2006 expiry date. Cell-dyn 22 calibrators and controls are subjected to stability testing per abbott department operating procedures. The cell-dyn 22 calibrators and controls claim product shelf life and consecutive day open container stability. The calibrator and control values must meet the requirement within the published assay values and ranges per abbott stability testing parameters. The values recovered during stability testing are the same as product release values. An investigation was performed and probable causes were found to be a combination of the following issues: common cause process variability of the red blood cell fragmentation to platelet like particles affecting mean platelet volume, and special cause variation of tightening the platelet specification by 50%. It was determined that red blood cell fragmentation is enhanced by mechanical stress. These issues did not adequately predict an increase of platelet count through the established stability claims. The formulation and manufacturing process used in the manufacturing and testing of the cell-dyn 22 calibrators and controls are specific to both the calibrators and controls and does not impact the other instrument platforms, therefore the identified probable cause is product specific. The corrective action for the cell-dyn 22 calibrators and controls is to re-evaluate the platelet specification, improve assay assignment procedure for platelet parameter, re-validate the platelet manufacturing process to increase the mean platelet volume and conduct monthly value assignment. This is the final report.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2919069-2007-00152
MDR Report Key907924
Report Source01,04
Date Received2007-09-06
Date of Report2007-05-04
Date of Event2006-07-13
Date Mfgr Received2007-05-04
Device Manufacturer Date2006-05-01
Date Added to Maude2007-10-17
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationUNKNOWN
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactDR DAVID BARCH, D-09Y6, AP6C-2
Manufacturer Street100 ABBOTT PARK RD
Manufacturer CityABBOTT PARK IL 600646092
Manufacturer CountryUS
Manufacturer Postal600646092
Manufacturer Phone8479379328
Single Use3
Remedial ActionRC
Previous Use Code3
Removal Correction Number2919069-9/26/06-003-C
Event Type3
Type of Report3

Device Details

Brand NameCELL-DYN 22 TRI-LEVEL CONTROL
Generic NameCD22 CONTROLS
Product CodeJCN
Date Received2007-09-06
Model NumberNA
Catalog Number93111-01
Lot Number0125
ID NumberNA
Device Expiration Date2006-08-06
OperatorOTHER
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrY
Implant FlagN
Date RemovedB
Device Sequence No1
Device Event Key899542
ManufacturerABBOTT DIAGNOSTICS DIVISION/CELLDYN
Manufacturer Address5440 PATRICK HENRY DR. SANTA CLARA CA 95054 US


Patients

Patient NumberTreatmentOutcomeDate
10 2007-09-06

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.